- Home
- VALN vs NATH Comparison
VALN vs NATH Comparison
Compare VALN & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- NATH
- Stock Information
- Founded
- VALN 2012
- NATH 1916
- Country
- VALN France
- NATH United States
- Employees
- VALN N/A
- NATH N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- NATH Restaurants
- Sector
- VALN Health Care
- NATH Consumer Discretionary
- Exchange
- VALN Nasdaq
- NATH Nasdaq
- Market Cap
- VALN 345.2M
- NATH 323.4M
- IPO Year
- VALN 2021
- NATH N/A
- Fundamental
- Price
- VALN $4.36
- NATH $77.67
- Analyst Decision
- VALN Strong Buy
- NATH
- Analyst Count
- VALN 2
- NATH 0
- Target Price
- VALN $18.50
- NATH N/A
- AVG Volume (30 Days)
- VALN 68.4K
- NATH 9.3K
- Earning Date
- VALN 11-07-2024
- NATH 01-30-2025
- Dividend Yield
- VALN N/A
- NATH 2.56%
- EPS Growth
- VALN N/A
- NATH 11.31
- EPS
- VALN N/A
- NATH 5.34
- Revenue
- VALN $176,817,979.00
- NATH $143,757,000.00
- Revenue This Year
- VALN $24.66
- NATH N/A
- Revenue Next Year
- VALN $9.67
- NATH N/A
- P/E Ratio
- VALN N/A
- NATH $14.62
- Revenue Growth
- VALN N/A
- NATH 7.04
- 52 Week Low
- VALN $3.62
- NATH $63.01
- 52 Week High
- VALN $9.50
- NATH $94.97
- Technical
- Relative Strength Index (RSI)
- VALN 48.76
- NATH 40.79
- Support Level
- VALN $4.22
- NATH $75.15
- Resistance Level
- VALN $4.51
- NATH $78.47
- Average True Range (ATR)
- VALN 0.21
- NATH 1.50
- MACD
- VALN 0.00
- NATH 0.12
- Stochastic Oscillator
- VALN 41.90
- NATH 48.00
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.